Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Prelude Therapeutics Incorporated (PRLD)
Pharmaceutical Preparations
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
200 POWDER MILL ROAD
WILMINGTON, DE
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/25/2020
Market Cap
295,246,417
Shares Outstanding
54,830,000
Weighted SO
54,831,493
Total Employees
N/A
Upcoming Earnings
08/01/2024
Beta
1.5350
Last Div
0.0000
Range
1.66-6.8
Chg
-0.3950
Avg Vol
109233
Mkt Cap
295246417
Exch
NASDAQ
Country
US
Phone
302 467 1280
DCF Diff
5.3308
DCF
0.1392
Div Yield
0.0000
P/S
86.2285
EV Multiple
-2.0187
P/FV
2.2341
Div Yield %
0.0000
P/E
-3.1360
PEG
-0.2847
Payout
0.0000
Current Ratio
7.8300
Quick Ratio
7.8300
Cash Ratio
1.1925
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
1513.4745
CCC
-1513.4745
Gross Margin
0.5654
Op Margin
-41.5511
Pretax Margin
-37.9246
Net Margin
-37.9246
Eff Tax Rate
-0.0075
ROA
-0.5790
ROE
-0.5982
ROCE
-0.7080
NI/EBT
1.0000
EBT/EBIT
0.9127
EBIT/Rev
-41.5511
Debt Ratio
0.0812
D/E
0.0999
LT Debt/Cap
0.0782
Total Debt/Cap
0.0908
Int Coverage
-101.8404
CF/Debt
-5.7190
Equity Multi
1.2305
Rec Turnover
0.0000
Pay Turnover
0.2412
Inv Turnover
0.0000
FA Turnover
0.0922
Asset Turnover
0.0153
OCF/Share
-1.3742
FCF/Share
-1.4054
Cash/Share
2.3738
OCF/Sales
-30.4057
FCF/OCF
1.0227
CF Coverage
-5.7190
ST Coverage
-38.0099
CapEx Coverage
-43.9649
Div&CapEx Cov
-43.9649
P/BV
2.2341
P/B
2.2341
P/S
86.2285
P/E
-3.1360
P/FCF
-2.7729
P/OCF
-3.9115
P/CF
-3.9115
PEG
-0.2847
P/S
86.2285
EV Multiple
-2.0187
P/FV
2.2341
DPS
0.0000